245 related articles for article (PubMed ID: 18688709)
1. The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model.
Chiba Y; Shimada A; Kumagai N; Yoshikawa K; Ishii S; Furukawa A; Takei S; Sakura M; Kawamura N; Hosokawa M
Neurochem Res; 2009 Apr; 34(4):679-87. PubMed ID: 18688709
[TBL] [Abstract][Full Text] [Related]
2. A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice.
Hosokawa M
Mech Ageing Dev; 2002 Nov; 123(12):1553-61. PubMed ID: 12470893
[TBL] [Abstract][Full Text] [Related]
3. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice.
Takeda T
Neurochem Res; 2009 Apr; 34(4):639-59. PubMed ID: 19199030
[TBL] [Abstract][Full Text] [Related]
4. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research.
Takeda T
Neurobiol Aging; 1999; 20(2):105-10. PubMed ID: 10537019
[TBL] [Abstract][Full Text] [Related]
5. Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8.
Sureda FX; Gutierrez-Cuesta J; Romeu M; Mulero M; Canudas AM; Camins A; Mallol J; Pallàs M
Exp Gerontol; 2006 Apr; 41(4):360-7. PubMed ID: 16542809
[TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of senescence-accelerated mouse (SAM).
Higuchi K
Exp Gerontol; 1997; 32(1-2):129-38. PubMed ID: 9088910
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes.
Tanisawa K; Mikami E; Fuku N; Honda Y; Honda S; Ohsawa I; Ito M; Endo S; Ihara K; Ohno K; Kishimoto Y; Ishigami A; Maruyama N; Sawabe M; Iseki H; Okazaki Y; Hasegawa-Ishii S; Takei S; Shimada A; Hosokawa M; Mori M; Higuchi K; Takeda T; Higuchi M; Tanaka M
BMC Genomics; 2013 Apr; 14():248. PubMed ID: 23586671
[TBL] [Abstract][Full Text] [Related]
8. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach.
Okuma Y; Nomura Y
Jpn J Pharmacol; 1998 Dec; 78(4):399-404. PubMed ID: 9920195
[TBL] [Abstract][Full Text] [Related]
9. [Senescence-accelerated mouse (SAM): with special reference to age-associated pathologies and their modulation].
Takeda T
Nihon Eiseigaku Zasshi; 1996 Jul; 51(2):569-78. PubMed ID: 8783874
[TBL] [Abstract][Full Text] [Related]
10. Aging of blood-brain barrier and neuronal cells of eye and ear in SAM mice.
Hosokawa M; Ueno M
Neurobiol Aging; 1999; 20(2):117-23. PubMed ID: 10537021
[TBL] [Abstract][Full Text] [Related]
11. Senescence-accelerated mouse (SAM): a novel murine model of senescence.
Takeda T; Hosokawa M; Higuchi K
Exp Gerontol; 1997; 32(1-2):105-9. PubMed ID: 9088907
[TBL] [Abstract][Full Text] [Related]
12. Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse.
Phan VL; Miyamoto Y; Nabeshima T; Maurice T
J Neurosci Res; 2005 Feb; 79(4):561-72. PubMed ID: 15635598
[TBL] [Abstract][Full Text] [Related]
13. [Anti-aging studies on the senescence accelerated mouse (SAM) strains].
Takahashi R
Yakugaku Zasshi; 2010 Jan; 130(1):11-8. PubMed ID: 20046059
[TBL] [Abstract][Full Text] [Related]
14. Genetic typing of the senescence-accelerated mouse (SAM) strains with microsatellite markers.
Xia C; Higuchi K; Shimizu M; Matsushita T; Kogishi K; Wang J; Chiba T; Festing MF; Hosokawa M
Mamm Genome; 1999 Mar; 10(3):235-8. PubMed ID: 10051317
[TBL] [Abstract][Full Text] [Related]
15. Differences in saccharin preference and genetic alterations of the Tas1r3 gene among senescence-accelerated mouse strains and their parental AKR/J strain.
Niimi K; Takahashi E
Physiol Behav; 2014 May; 130():108-12. PubMed ID: 24726396
[TBL] [Abstract][Full Text] [Related]
16. Cultured murine dermal fibroblast-like cells from senescence-accelerated mice as in vitro models for higher oxidative stress due to mitochondrial alterations.
Chiba Y; Yamashita Y; Ueno M; Fujisawa H; Hirayoshi K; Hohmura K; Tomimoto H; Akiguchi I; Satoh M; Shimada A; Hosokawa M
J Gerontol A Biol Sci Med Sci; 2005 Sep; 60(9):1087-98. PubMed ID: 16183946
[TBL] [Abstract][Full Text] [Related]
17. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.
Butterfield DA; Poon HF
Exp Gerontol; 2005 Oct; 40(10):774-83. PubMed ID: 16026957
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic deficits in the septal-hippocampal pathway of the SAM-P/8 senescence accelerated mouse.
Strong R; Reddy V; Morley JE
Brain Res; 2003 Mar; 966(1):150-6. PubMed ID: 12646318
[TBL] [Abstract][Full Text] [Related]
19. Age-dependency of the serum oxidative level in the senescence-accelerated mouse prone 8.
Taniguchi S; Hanafusa M; Tsubone H; Takimoto H; Yamanaka D; Kuwahara M; Ito K
J Vet Med Sci; 2016 Sep; 78(8):1369-71. PubMed ID: 27149963
[TBL] [Abstract][Full Text] [Related]
20. Accelerated aging of dermal fibroblast-like cells from senescence-accelerated mouse (SAM). 1. Acceleration of population aging in vitro.
Hosokawa M; Ashida Y; Nishikawa T; Takeda T
Mech Ageing Dev; 1994 May; 74(1-2):65-77. PubMed ID: 7934209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
